Veralto is a high-quality, recurring-revenue water and product quality compounder trading at an attractive valuation despite durable regulatory tailwinds and defensive cash flows.
Overview
Veralto is a high-quality industrial technology compounder built around mission-critical water diagnostics, treatment, disinfection, marking, coding, packaging workflow, and color-standard technologies. The company benefits from regulated end markets, high customer switching costs, and a highly recurring revenue base: recurring sources represented 61.04% of FY2025 sales, or $3.359 billion of total sales of $5.503 billion. Its Water Quality segment contributed 60.35% of FY2025 revenue, while Product Quality & Innovation contributed 39.65%. The investment case is anchored in essential-use products such as Hach analyzers and reagents, ChemTreat industrial water chemicals, Trojan UV disinfection systems, Videojet printers and inks, Esko packaging workflow software, and Pantone color standards. **The central attraction is predictable free cash flow from embedded consumables, software, and compliance-driven demand.** Veralto’s Q2 2026 results reinforced the quality thesis: net sales grew 7.6% year over year to $1.474 billion, non-GAAP core sales rose 4.2%, adjusted operating margin expanded to 24.6%, and adjusted diluted EPS of $1.11 beat consensus by roughly $0.10. Management raised FY2026 adjusted EPS guidance to $4.35-$4.43 and core sales growth guidance to 4.0%-4.5%. The stock traded at $97.16 on August 5, 2026, equal to roughly 22.13x the midpoint of raised 2026 EPS guidance. That valuation limits near-term multiple expansion, but the company’s high gross margins near 60%, ROE around 34.37%-35.90%, low capital intensity near 1% of sales, and approximately 100% free cash flow conversion support durable compounding. The probability-weighted 5-year scenario target is $125.52, implying a 29.19% cumulative return and 5.26% annualized return from $97.16.